Psychedelic Therapy Shows Promise for Long-Term Depression Relief

Watch Psychedelic Therapy Shows Promise for Long-Term Depression Relief - Rizzle on Dailymotion

Transcript

00:00Psychedelic therapy shows promise for long-term depression relief.

00:05Depression affects over 18 million U.S. adults yearly and leads to more than 41,000 suicides.

00:12Traditional treatments include medication and therapy, but new research from Ohio State

00:16University suggests psychedelic-assisted therapy may offer lasting relief.

00:21How does it differ from current treatments? Let's find out.

00:24Building on a 2021 trial with 24 participants with major depressive disorder, researchers

00:34followed 18 people over five years. Participants received two psilocybin doses plus therapy

00:40and completed questionnaires and clinician assessments. At one year, 58% were in remission,

00:46rising to 67% at five years. Lead author Alan Davis noted lasting improvements in depression,

00:52anxiety, and overall functioning, emphasizing the importance of strong therapist support.

00:58While some tried psychedelics alone, clinical guidance proved far more effective.

01:05Only 18 of 24 participants joined the five-year follow-up. Even assuming the rest relapsed,

01:11results showed significant depression reduction. Without a control group and with many using other

01:16treatments, benefits can't be solely credited to psilocybin. Still, participants reported lasting

01:22improvements in how they managed and related to depression.